Hazlett, Burt & Watson’s Covetrus, Inc. Common Stock CVET Stock Holding History

Hazlett, Burt & Watson’s Portfolio CVET Stock Details CVET Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-760	Closed	-$17K	–	656
2022 Q3	$17K	Buy	760 +80	+12%	+$1.67K	0.02%	398
2022 Q2	$14K	Hold	680	–	–	0.01%	424
2022 Q1	$11K	Buy	+680	New	+$11.9K	0.01%	466

Other funds holding CVET

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

CAS

Coppell Advisory Solutions Coppell, Texas $170M AUM 13.42% 1-Year Est. Return

CASC

Coppell Advisory Solutions Corp Coppell, Texas $531M AUM

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Hazlett, Burt & Watson's CVET Position: Q4 2022 in Review

Hazlett, Burt & Watson sold out of Covetrus, Inc. Common Stock (CVET) in Q4 2022, closing a stake of 760 shares — an estimated $17K sold.

Hazlett, Burt & Watson first reported a position in CVET in Q1 2022 and held it in 3 quarters. The position peaked at $17K in Q3 2022. 5 funds tracked by Wall St. Rank hold CVET as of Q4 2022.

Hazlett, Burt & Watson reported no remaining Covetrus, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
Hazlett, Burt & Watson sold 760 Covetrus, Inc. Common Stock shares in Q4 2022, an estimated $17K.
Hazlett, Burt & Watson first reported a position in Covetrus, Inc. Common Stock in Q1 2022 and held it in 3 quarters.
Hazlett, Burt & Watson's Covetrus, Inc. Common Stock position peaked at $17K in Q3 2022.
5 funds tracked by Wall St. Rank held Covetrus, Inc. Common Stock as of Q4 2022.

Based on Hazlett, Burt & Watson's 13F filing for Q4 2022, filed 25 Jan 2023.